Skip to main content
Clinical Trials/NCT07317765
NCT07317765Active, not recruitingNot Applicable

Research on New Methods and New Models of Rehabilitation Intervention for Cancer Patients Based on Exercise and Psychological Intervention

Beijing HuiLongGuan Hospital1 site in 1 country200 target enrollmentStarted: March 17, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
200
Locations
1
Primary Endpoint
SAS score

Study Overview

Brief Summary

A Randomized Controlled Trial of Natural Psychotherapy for Intervening Negative Emotions in 100 Breast Cancer Patients

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 59 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients with pathologically confirmed breast cancer, no distant metastasis, who have completed the perioperative period and not received subsequent treatment;
  • Aged 18-59 years with an expected survival period of ≥ 1 year;
  • Breast cancer patients with a self-reported depression score of ≥ 53 and/or anxiety score of ≥ 50 on self-rating scales (e.g., Self-Rating Depression Scale [SDS], Self-Rating Anxiety Scale [SAS]);
  • Voluntarily participating in the study after providing informed consent and signing the informed consent form.

Exclusion Criteria

  • Patients with advanced breast cancer (stage IV with distant metastasis);
  • Patients receiving other psychological interventions besides this study (e.g., individual counseling, group therapy);
  • Patients with severe mental illness (e.g., schizophrenia), cognitive impairment (MMSE score < 24), heart disease, severe physical illness, other cancers, or complications;
  • Patients who are unable to cooperate with psychological interventions, questionnaires, or interviews; patients who request or voluntarily withdraw from this study.

Outcomes

Primary Outcomes

SAS score

Time Frame: 5 weeks

Self-Rating Anxiety Scale (SAS) Score range: The total score ranges from 20 to 80 after standard conversion. Interpretation of scores: Higher scores indicate more severe anxiety symptoms; conversely, lower scores reflect milder or no anxiety symptoms.

SDS score

Time Frame: 5 weeks

Self-Rating Depression Scale (SDS) Score range: The total score ranges from 20 to 80 after standard conversion. Interpretation of scores: Higher scores represent more severe depressive symptoms; on the contrary, lower scores mean less severe or no depressive symptoms.

Secondary Outcomes

  • Ruminative Response Scale(5 weeks)
  • Connor-Davidson Resilience Scale(5 weeks)
  • ACC score(5 weeks)
  • Functional Assessment of Cancer Therapy-Breast (FACT-B)(5 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Xiang Yang Zhang

Professor

Beijing HuiLongGuan Hospital

Study Sites (1)

Loading locations...

Similar Trials